培非格司亭中英文介绍.docxVIP

王婕 913103860408 NEULASTA（PEGFILGRASTIM）|培非格司亭注射液 1. Introduction(简介)  INCLUDEPICTURE /uploadfile/article/uploadfile/201103/20110308065306976.jpg \* MERGEFORMATINET  【产地英文商品名】:NEULASTA－6mg/0.6ml/Syringe? 【原产地英文药品名】:PEGFILGRASTIM 【中文参考商品译名】:纽拉思塔-6毫克/0.6毫升/支? 【中文参考药品译名】:培非格司亭 【生产厂家中文参考译名】:安进 【生产厂家英文名】:Amgen, Inc Amgen Announces Novel Drugs for Antitumor Chemotherapy Side Effects of FGT (TM) (pegfilgrastim), a drug developed by the US Food and Drug Administration (FDA), has been approved by the US Food and Drug Administration (FDA) Approval. Amphetamycin, the chief executive of Amgen, says that pemetrexedin will make it easier for healthcare workers to prevent chemotherapy-induced neutropenia and its serious complications. The third drug approved by Amgen in the past six months will significantly improve the prognosis of chemotherapy patients and is expected to enter the market in early April. BUSINESS WIRE 2002年2月1日美国加州THOUSAND OAKS消息， 安进公司宣布抗肿瘤化疗副作用新药培非格司亭(TM) (pegfilgrastim)通过美国食品与药品管理局（FDA）的审批。安进公司首席执行官Kevin Sharer说，培非格司亭会使医务人员预防化疗患者出现中性粒细胞减少症及其严重的并发症相对容易。培非格司亭是安进公司在过去的6个月中获得批准的第三个药物，它将大大改观化疗患者的预后，有望在4月初进入销售市场。 2.Function(功能） Pegfilgrastim to patients with chronic myelodysplastic syndrome such as myelodysplastic syndrome, periodic neutropenia and aplastic anemia and other effects is very obvious, as well as chemotherapy-induced decrease in the number of white blood cells, pegfilgrastim can enhance the number of white blood cells. 培非格司亭对慢性粒细胞缺乏症病人如骨髓异常增生综合征、周期性中性粒细胞缺乏症和再生障碍性贫血等疗效非常明显，以及因化疗致白细胞数减少者，培非格司亭可提升白细胞数。 As an antitumor chemotherapeutic side effect, pegfilgrastim is effective in reducing the incidence of infection during chemotherapy, which is often associated with fever associated with neutropenia (ie, fever and anti-infective A serious decline in the number of white blood cells). 作为一种抗肿瘤化疗副作用的药物，培非格司亭适用于减低化疗过程中感染的发生率,这种感染常常表现为中性粒细胞减少症引起的相关的发热(即发热与抗感染的白细胞数量的严重下降有关)。 Neutropenia is a common complication of chemotherapy in cance